Aptinyx Inc reported $21.21M in Operating Expenses for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Operating Expenses Change
Acadia Pharmaceuticals ACAD:US $ 146.91M 12.02M
Acorda Therapeutics ACOR:US $ 54.46M 6.99M
Adamas Pharmaceuticals ADMS:US 31.53M 405K
Biogen BIIB:US $ 1984.9M 304.4M
Cara Therapeutics CARA:US $ 21.4M 9.48M
Daiichi Sankyo 4568:JP 226.92B 8.62B
Eli Lilly And LLY:US $ 5296.8M 39.9M
Gw Pharmaceuticals GWPH:US 173.49M 2.46M
Halozyme Therapeutics HALO:US $ 40.24M 3.16M
Intra Cellular Therapies ITCI:US $ 99.53M 10.34M
IONIS PHARMACEUT IONS:US $ 219M 11.65M
Marinus Pharmaceuticals MRNS:US $ 29.28M 3.89M
Neurocrine Biosciences NBIX:US $ 251.5M 25.4M
Novartis NOVN:VX 10.13B 319M
Ultragenyx Pharmaceutical RARE:US $ 171.48M 1.72M
Vertex Pharmaceuticals VRTX:US $ 929.65M 901.68M